Nexus Pharmaceuticals Inc recalls Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nex
Recalled September 4, 2013 · FDA recall D-925-2013 · Nexus Pharmaceuticals
Hazard
Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination. · FDA Class II
Units
46,185 vials
Sold at
Nationwide
Description
Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.
Product
Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069, NDC 14789-300-02
Manufacturer(s)
Nexus Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →